NL7810562A - Ureumderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten. - Google Patents

Ureumderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten.

Info

Publication number
NL7810562A
NL7810562A NL7810562A NL7810562A NL7810562A NL 7810562 A NL7810562 A NL 7810562A NL 7810562 A NL7810562 A NL 7810562A NL 7810562 A NL7810562 A NL 7810562A NL 7810562 A NL7810562 A NL 7810562A
Authority
NL
Netherlands
Prior art keywords
preparing
pharmaceutical preparations
urea derivatives
urea
derivatives
Prior art date
Application number
NL7810562A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH546578A external-priority patent/CH642944A5/de
Priority claimed from CH546678A external-priority patent/CH639846A5/de
Priority claimed from CH940778A external-priority patent/CH644850A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL7810562A publication Critical patent/NL7810562A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NL7810562A 1977-10-28 1978-10-23 Ureumderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten. NL7810562A (nl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
LU78407 1977-10-28
LU78408 1977-10-28
CH546578A CH642944A5 (en) 1978-05-19 1978-05-19 Urea derivatives
CH546678A CH639846A5 (en) 1978-05-19 1978-05-19 Pharmaceutical preparations having antiandrogenic action, containing urea derivatives or hydantoin derivatives
CH940778A CH644850A5 (en) 1977-10-28 1978-09-07 Pharmaceutical preparations containing urea derivatives

Publications (1)

Publication Number Publication Date
NL7810562A true NL7810562A (nl) 1979-05-02

Family

ID=27509239

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7810562A NL7810562A (nl) 1977-10-28 1978-10-23 Ureumderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten.

Country Status (15)

Country Link
US (1) US4234736A (xx)
JP (1) JPS5473754A (xx)
AU (2) AU522796B2 (xx)
BE (1) BE871584A (xx)
BR (1) BR7807115A (xx)
CA (2) CA1138334A (xx)
DE (1) DE2846945A1 (xx)
DK (1) DK481778A (xx)
FR (1) FR2407205A1 (xx)
GB (2) GB2087870B (xx)
IL (1) IL55774A (xx)
IT (1) IT1100904B (xx)
NL (1) NL7810562A (xx)
NZ (1) NZ188720A (xx)
SE (2) SE433304B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
FI801184A (fi) * 1979-04-24 1980-10-25 Hoffmann La Roche Foerfarande foer framstaellning av imidazolidinderivat
EP0091596B1 (de) * 1982-04-08 1991-09-11 Shell Internationale Researchmaatschappij B.V. Neue Hydantoine, ihre Herstellung und Verwendung
JP2791156B2 (ja) * 1988-08-23 1998-08-27 ザ ヌトラスウィート カンパニー 強力甘味料としての置換アリール尿素
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2671348B1 (fr) * 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5670641A (en) * 1995-06-02 1997-09-23 American Cyanamid Company 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7001911B2 (en) * 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
CN1454083A (zh) 2000-06-28 2003-11-05 布里斯托尔-迈尔斯斯奎布公司 选择性雄激素受体调节剂及其鉴定、设计和应用的方法
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
JP4434740B2 (ja) 2001-12-19 2010-03-17 ブリストル−マイヤーズ スクイブ カンパニー 核ホルモン受容体機能の調節剤である、縮合ヘテロ環化合物およびその類似体
JP2007514442A (ja) * 2003-12-19 2007-06-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 前立腺癌治療を評価するための方法および物質
WO2005099693A2 (en) * 2004-02-24 2005-10-27 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
EP3835294A1 (en) * 2006-03-27 2021-06-16 The Regents of The University of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
NZ596260A (en) 2006-03-29 2013-05-31 Univ California Diarylthiohydantoin compounds
JP5535925B2 (ja) 2007-10-26 2014-07-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物
SG10201501202TA (en) 2010-02-16 2015-04-29 Aragon Pharmaceuticals Inc Androgen Receptor Modulators And Uses Thereof
SG10201912719TA (en) 2012-09-26 2020-02-27 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
SG11202003402QA (en) 2017-10-16 2020-05-28 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629779A (xx) *
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
GB997037A (en) 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
IL31416A0 (en) 1968-02-19 1969-03-27 Bayer Ag 5-imino-2-oxo-imidazolidines,their preparation and use as herbicides
DK122816B (da) * 1968-03-28 1972-04-17 Ciba Geigy Ag Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner.
DK123717B (da) * 1968-11-25 1972-07-24 Sumitomo Chemical Co 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
US3676456A (en) * 1970-02-27 1972-07-11 Ciba Geigy Corp Derivatives of 3-aryl-5-alkylhydantoins
JPS5136332B1 (xx) * 1970-12-09 1976-10-07
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
IL45459A (en) 1973-09-03 1978-01-31 Ciba Geigy Ag 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant

Also Published As

Publication number Publication date
IL55774A (en) 1982-04-30
FR2407205B1 (xx) 1982-12-31
BE871584A (fr) 1979-04-27
AU522796B2 (en) 1982-06-24
US4234736A (en) 1980-11-18
AU8105182A (en) 1982-07-08
IT7829207A0 (it) 1978-10-27
DK481778A (da) 1979-04-29
GB2008101B (en) 1982-09-08
FR2407205A1 (fr) 1979-05-25
IT1100904B (it) 1985-09-28
GB2087870A (en) 1982-06-03
IL55774A0 (en) 1978-12-17
SE7811193L (sv) 1979-04-29
NZ188720A (en) 1984-12-14
JPS5473754A (en) 1979-06-13
CA1137091A (en) 1982-12-07
SE433304B (sv) 1984-05-21
BR7807115A (pt) 1979-05-15
GB2087870B (en) 1982-11-10
AU4096278A (en) 1980-05-01
DE2846945A1 (de) 1979-05-03
GB2008101A (en) 1979-05-31
AU551161B2 (en) 1986-04-17
SE8202106L (sv) 1982-04-01
CA1138334A (en) 1982-12-28

Similar Documents

Publication Publication Date Title
NL7810562A (nl) Ureumderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten.
NL7800363A (nl) Nieuwe 4.9-dieen-11b-gesubstitueerde steroid- derivaten, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze steroid- derivaten bevatten.
NL7704057A (nl) Werkwijze ter bereiding van nieuwe cefolosporine- derivaten, werkwijze ter bereiding van farmaceu- tische preparaten en gevormde farmaceutische preparaten.
NL7803486A (nl) Cefemderivaten alsmede werkwijze ter bereiding daarvan.
NL7800824A (nl) Insecticideverbindingen, preparaten die deze bevatten, alsmede werkwijzen ter bereiding daarvan.
NL7812312A (nl) Stilbeenderivaten en werkwijzen ter bereiding ervan.
NL7803626A (nl) 2-alkyleenaminodihydropyridinen, werkwijzen ter berei- ding ervan, alsmede farmaceutische preparaten.
NL7804345A (nl) Imidazoazinen en imidazodiazinen, werkwijze ter berei- ding daarvan en farmaceutische preparaten.
NL7609735A (nl) Polyalkeenpreparaten, alsmede werkwijze ter bereiding ervan.
NL7710502A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten alsmede werkwijze ter bereiding van nieuwe, analgetisch werkzame verbindingen.
NL7804230A (nl) N-alkyl-n-acylderivaten van thienamycine, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten.
NL7800195A (nl) Poedervormige kleurstofpreparaten, werkwijzen ter bereiding en toepassing ervan.
NL7712559A (nl) Piperidinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
NL7802892A (nl) Pseudotrisacchariden, werkwijzen ter bereiding ervan en farmaceutische preparaten.
NL7809404A (nl) Thiazoolderivaten en thiazoolderivaten bevattende farmaceutische preparaten, alsmede werkwijzen voor het bereiden van een en ander.
NL7806380A (nl) Pyrazolyl-pyridazinederivaten, werkwijze voor de berei- ding hiervan alsmede de therapeutische toepassing.
NL184467C (nl) 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.
NL7803162A (nl) Nieuwe 1-aminoindaanderivaten, alsmede farmaceutische preparaten die deze bevatten.
NL7802526A (nl) Nieuwe 1-azaxanthonverbindingen, werkwijze ter bereiding daarvan en farmaceutische preparaten.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
NL7803877A (nl) P.aminomethylbenzeensulfonamidederivaten, werkwijze ter bereiding daarvan en toepassing daarvan.
NL7802826A (nl) Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten.
NL7810700A (nl) Ureumderivaten, de bereidingswijze en toepassing daarvan.
NL7711936A (nl) Ureumderivaten en werkwijze voor de bereiding en toepassing ervan.
NL7804168A (nl) Nieuwe naftyridinen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
BC A request for examination has been filed
BV The patent application has lapsed